Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1383992Generated: October 29, 2026

2-(4-Chlorophenoxymethyl)-4-benzyloxy-1-[3-[1-(t-butoxycarbonyl)piperidin-3-yl]propyl]-benzimidazole → (RS) 2-(4-chlorophenoxymethyl)-4hydroxy-1-[3-[1-(t-butoxycarbonyl)piperidin-3-yl]propyl]benzimidazole

https://huagongshe.com/reaction/1383992

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-(4-Chlorophenoxymethyl)-4-benzyloxy-1-[3-[1-(t-butoxycarbonyl)piperidin-3-yl]propyl]-benzimidazoleHCID 21188484—
CatalystPalladiumHCID 23938—
SolventEthyl AcetateHCID 8857—
Product(RS) 2-(4-chlorophenoxymethyl)-4hydroxy-1-[3-[1-(t-butoxycarbonyl)piperidin-3-yl]propyl]benzimidazoleHCID 2118857678%

Reaction Steps

A solution of (RS) 2-(4-chlorophenoxymethyl)-4-benzyloxy-1-[3-[1-(t-butoxycarbonyl)piperidin-3-yl]propyl]-benzimidazole (245 mg, 0.42 mmol, 1.0 eq) in ethyl acetate (4.2 ml) was degassed and then treated with 5% palladium on carbon (250 mg). The resulting mixture was stirred under a hydrogen atmosphere. The reaction mixture was then filtered through a CELITE™ cake layer. The catalyst was washed thoroughly with ethyl acetate and ethanol. The filtrate was condensed on a rotoevaporator to yield the desired title product in 78% yield.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06255494B1
Source datasetuspto-grants-2001_07
ORD IDord-fc018d48ef794f65ab2382653a731236
Source noteuspto-grants-2001_07